This NDC is on FDA's drug shortage list (posted Nov 3, 2023)
Product Information
CROMOLYN 100 MG/5 ML ORAL CONC is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.3490 per ML under NDC 16571060096. Its NADAC has been published 635 times since Nov 28, 2013.
FDA first approved this application on Oct 27, 2011. Its Orange Book therapeutic-equivalence code is AA.
Strength
100 mg/5mL
Manufacturer
Rising Pharma Holdings Inc.NDC
16571060096
Classification
Generic
Dosage Form
SOLUTION, CONCENTRATE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CROMOLYN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA202583FDA Approved
10/27/2011
TE Code
AA
On Market Since
12/5/2011
Pharmacological Classes
Price Statistics
The NADAC for CROMOLYN 100 MG/5 ML ORAL CONC has been published 635 times since Nov 28, 2013, and over the history we have for it it has declined 60.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3490 per ML |
|---|---|
| All-time high | $1.0317 (Jun 10, 2015) |
| All-time low | $0.1665 (Nov 20, 2024) |
| 52-week high | $0.3490 |
| 52-week low | $0.3141 |
| Median price | $0.4775 |
| Average price | $0.5762 |
| Largest weekly change | +85.7% (Jan 17, 2024) |
| Weeks tracked | 635 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CROMOLYN SODIUM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Mast Cell Stabilizer class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CROMOLYN 100 MG/5 ML ORAL CONC?
The current National Average Drug Acquisition Cost (NADAC) for CROMOLYN 100 MG/5 ML ORAL CONC, manufactured by Rising Pharma Holdings Inc., is $0.3490 per ML (NDC 16571060096), effective Sep 30, 2026.
How has the price of CROMOLYN 100 MG/5 ML ORAL CONC changed over time?
Over the history we have for it, the NADAC for CROMOLYN 100 MG/5 ML ORAL CONC has declined 60.8%. It has been tracked across 635 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CROMOLYN 100 MG/5 ML ORAL CONC?
Since Nov 28, 2013, the NADAC for CROMOLYN 100 MG/5 ML ORAL CONC has ranged from a low of $0.1665 (Nov 20, 2024) to a high of $1.0317 (Jun 10, 2015), with a median of $0.4775 per ML.
Are there cheaper alternatives to CROMOLYN 100 MG/5 ML ORAL CONC?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CROMOLYN 100 MG/5 ML ORAL CONC in a comparable dosage form, but none are currently priced below it.
Who manufactures CROMOLYN 100 MG/5 ML ORAL CONC?
CROMOLYN 100 MG/5 ML ORAL CONC (NDC 16571060096) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Is CROMOLYN 100 MG/5 ML ORAL CONC in shortage?
Yes — NDC 16571060096 is currently listed in FDA's drug shortage database (posted Nov 3, 2023).